Bullseye Breakdown - Ep. 111 - Brian Feth - Scaling Cell Therapy and Using AI to Fight Cancer
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Bullseye Breakdown - Ep. 111 - Brian Feth - Scaling Cell Therapy and Using AI to Fight Cancer
-
ナレーター：
-
著者：
このコンテンツについて
What if cancer could be treated using your own supercharged immune cells?
In this episode of Bullseye Breakdown, host Dustin Weaver sits down with Brian Feth, CEO of Xcellbio, to unpack the future of cancer treatment through immune cell therapy, AI-driven potency testing, and scalable biotech manufacturing.
We cover:
How CAR-T therapies are shifting from “last resort” to front-line treatment
Why scaling biotech is like surgery — not software
How AI and impedance readers are changing the way we measure cancer-fighting potency
Building a platform that helps cure patients and generate revenue before FDA approval
The emotional toll of biotech — and how to lead through it
Brian also shares the worst advice he ever received, and how his team has built a company that’s saving lives — and scaling with grit.
If you care about cancer research, biotech startups, or what it takes to grow a mission-driven business in a brutal industry, this one’s a must-listen.
🎯 Follow Bullseye Breakdown for unfiltered founder stories that aim higher.